ERN1 and neoplasm: In contrast, systemic pharmacological inhibition of IRE1α with G9668 substantially attenuated tumor progression as compared with vehicle treatment (Fig. 5 A; and Fig. S4, C and D), suggesting enhancement of host-mediated anti-tumor activity.